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Objective: The purpose of the work was to estimate the
dose received by the heart throughout a course of
breath-holding breast radiotherapy.
Methods: 113 cone-beam CT (CBCT) scans were acquired
for 20 patients treated within the HeartSpare 1A study,
in which both an active breathing control (ABC) device
and a voluntary breath-hold (VBH) method were used.
Predicted mean heart doses were obtained from treat-
ment plans. CBCT scans were imported into a treatment
planning system, heart outlines defined, images regis-
tered to the CT planning scan and mean heart dose
recorded. Two observers outlined two cases three times
each to assess interobserver and intraobserver variation.
Results: There were no statistically significant differences
between ABC and VBH heart dose data from CT planning
scans, or in the CBCT-based estimates of heart dose, and
no effect from the order of the breath-hold method.
Variation in mean heart dose per fraction over the three
imaged fractions was ,6cGy without setup correction,
decreasing to 3.3cGy with setup correction. If scaled to 15
fractions, all differences between predicted and esti-
mated mean heart doses were ,0.5Gy and in 80% of
cases, they were ,0.25Gy.
Conclusion: Variation in mean heart dose was at an
acceptable level over the duration of breath-holding radio-
therapy and was well predicted by the planning system.
Advances in knowledge: Mean heart dose was not
adversely affected by fraction-to-fraction variations
throughout a course of heart-sparing radiotherapy using
two well-established breath-holding methods.
INTRODUCTION
A reduction in local recurrence and a decrease in mortality
result from the use of radiotherapy as a therapeutic agent
for breast cancer.1 Whilst this is a positive effect of radio-
therapy, the Early Breast Cancer Trialists’ Collaborative
Group meta-analysis of 2005 suggests an increase in late
non-breast cancer-related mortality associated with radio-
therapy, a large component of which is due to cardiovas-
cular disease.2 More recent evidence suggests that there is
no mean heart dose threshold for radiation-related cardiac
effects.3 This evidence has driven efforts to investigate and
implement techniques to reduce cardiac radiation exposure
whilst maintaining target coverage in breast cancer radio-
therapy including intensity-modulated radiotherapy, prone
positioning and breathing manoeuvres.4–6
Breath-holding is effective in reducing the cardiac radiation
dose.6–8 The setup reproducibility of breathing control
methods is shown to be of the order of 3mm for both
systematic and random error.8,9 Electronic portal imaging
(EPI) movie loops and EPI dosimetry conﬁrm consistency
and stability during radiation delivery.10,11 These imply
that radiation dose received by the heart is maintained
close to the level predicted in the radiotherapy treatment
plan. There will be differences in received dose from that
predicted as setup and breath-hold variations, although
small, do occur fraction to fraction, and often thresholds
are used in breast cancer radiotherapy so that setup error is
not corrected below an action level. Conﬁrming the impact
of these variations on mean heart dose is not trivial, as
volumetric imaging information is not available during
radiation delivery for most breast radiotherapy treatments.
Borst et al9 and McIntosh et al12 focused on a detailed
comparison of a breathing control method with free
breathing, covering aspects such as patient position re-
producibility and organ-at-risk doses from treatment
plans. Alderliesten et al13 used heart outline information to
derive planning organ-at-risk margins for the heart in cases
where surface imaging was used to monitor a breath-hold
treatment. In none of these studies were heart dose data esti-
mated throughout the treatment duration or for both
equipment-assisted and voluntary breath-hold (VBH)
techniques.
This study reports a retrospective analysis of mean heart dose
using cone-beam CT (CBCT) images acquired immediately
prior to breath-holding breast cancer radiotherapy. The study
purpose was to estimate received mean heart dose, to determine
any differences between two breath-hold methods and evaluate
any variation over the treatment course.
METHODS AND MATERIALS
Patient cohort and imaging data
The data used in this study were obtained from the HeartSpare
1A clinical trial comparing active breathing control (ABC) with
VBH. Treatment veriﬁcation was carried out using megavoltage
EPI. In addition, kilovoltage CBCT images were acquired on an
Elekta AB (Publ), Stockholm, Sweden X-ray volumetric imaging
system14 on ﬁrst, third and ﬁfth fractions per breath-hold
technique. Data retrieval issues meant 20/23 cases were available
with 113 associated CBCT data sets. These were exported to
a Philips Radiation Oncology Systems, Madison, Wisconsin, US
Pinnacle treatment planning system for rigid registration with
the planning CT scan for heart delineation and dose calculation.
Organ delineation
A CBCT image acquisition time of 30 s required two breath-
holds, which introduced blurring artefacts to the images (the
acquisition could not be interrupted during the exposure). The
adequacy of the image information for outlining was assessed
by visual inspection by two experienced practitioners (a ther-
apeutic radiographer and a clinical oncologist) working with
the cardiac outlining guidance of a clinical trial protocol.
Both practitioners outlined the heart on one ABC and one
VBH scan from the same case three times at 2-week intervals.
One practitioner (Observer 1) repeated the sequence of
outlining on a second case. All other cases were outlined by
Observer 1.
Data and analysis
The heart outlines from the imported CBCT images appeared as
structures on the plans used for treatment. Mean heart dose data
were collected. The gold standard data were the predicted mean
heart dose from the treatment plans using CT planning scans.
Estimated doses were expressed as mean heart dose per fraction
(in centigray), as only ﬁve or six fractions were imaged and this
avoided assumptions about the missing data. Heart volumes
were recorded for the observer variation study.
Two conditions were considered: the ﬁrst where it was assumed
that no setup correction was made and the second, post-image
registration, where all setup errors were assumed to be cor-
rected, i.e. online daily correction. This was achieved by
exporting the X-ray volumetric CBCT images so that they were
in the same frame of reference as the CT planning scan but
without registration data, i.e. in a non-setup correction state.
The heart was outlined and dose data were acquired for this
condition. Then, rigid registration to the planning CT image was
carried out and heart dose data acquired in the corrected
position.
Data sets were compared (i) between ABC and VBH at pre-
treatment CT; (ii) between CBCT data for each breath-hold
method and the corresponding pre-treatment CT data; (iii)
between ABC and VBH CBCT-based data; and (iv) over the
treatment duration for each breath-hold technique.
The data were tested for normality using the Shapiro–Wilk test
and differences in the means or distributions were tested for
statistical signiﬁcance using an independent-samples two-sided
Student’s t-test or non-parametric Mann–Whitney U-test as
appropriate. The null hypothesis was no statistically signiﬁcant
difference between the means, or the distributions, and a p-value
of 0.05 was used as the threshold for statistical signiﬁcance.
Statistical analyses were carried out using IBM SPSS® Statistics v.
22 (IBM Corp., New York, NY; formerly SPSS Inc., Chicago, IL).
RESULTS
Whilst blurring occurred on the CBCT images, both observers
were able to outline the heart on the CBCT images. The stan-
dard deviation of volumes and mean heart doses from the repeat
outlining on the images was taken as a measure of the observer
variation: 77 cm3 (ABC images) and 87 cm3 (VBH images) for
the heart volumes and 2 cGy (both ABC and VBH images) for
the corresponding mean heart dose. Absolute volumes were
547 cm3 (ABC) and 543 cm3 (VBH) and absolute mean heart
doses were 99 cGy (ABC) and 95 cGy (VBH), assuming a 15-
fraction treatment.
Figure 1 shows mean heart dose per fraction (in centigray) for
each case for the ABC (upper panel) and VBH (lower panel)
methods, respectively, with and without setup error correction.
Correcting the setup error resulted in improvements in the
agreement with the gold standard data from the treatment plan
and/or reduction in the variation of the mean heart dose values.
As expected, there were no statistically signiﬁcant differences
between ABC and VBH techniques in the mean heart dose data
prediction based on CT planning scans. There were no statisti-
cally signiﬁcant differences in the estimated mean heart dose per
fraction between the outlines based on the CBCT scans and
those predicted for the corresponding CT-based treatment plans
for either breath-hold technique. Neither was there a statistically
signiﬁcant difference in estimated heart doses received between
the two breath-hold methods. There appeared no effect from the
order of breath-hold method (whether the patient started with
ABC or VBH). Variations from the expected mean heart dose
per fraction from the imaged fraction data were ,6 cGy, with
16/20 of cases showing changes of 2 cGy or less when online
correction of setup error was applied. Tables 1 and 2 summarizes
the data from the acquired imaging for both ABC and VBH. In
addition, data are scaled to 15 fractions assuming the variation
from the 3 imaged fractions represents the variation over all
fractions. These data are provided to give context to the results
with respect to the heart dose expected from completed treat-
ments in breath-hold.
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Figure 1. Mean heart dose per fraction for (a) active breathing control (ABC) and (b) voluntary breath-hold (VBH) techniques. Mean
heart dose per fraction is estimated from pre-treatment CT scan data and cone-beam CT (CBCT) images. Data are given both where
no setup error was corrected and where all error was corrected. It can be noted that data retrieval issues means there are no data
CBCT for Case 17.
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DISCUSSION
This work has shown that the radiation dose to the heart re-
ceived by patients throughout a course of breath-holding ra-
diotherapy for breast cancer is not statistical signiﬁcantly
different from that predicted, is not affected by the breath-
holding techniques investigated and varies by ,0.25Gy over the
whole treatment for the majority of cases.
Neither this work nor that of Borst et al9 and McIntosh et al12
was able to obtain volumetric data during each fraction of
treatment directly, which would enable a more accurate de-
termination of received heart dose. However, all three studies
show a similar pattern—estimates of cardiac dose with breath-
holding during treatment agree well with those predicted. The
reproducibility of breath-hold methods is similar, or better, than
generally reported values for free breathing.8,9 EPI dosimetry
and cine, or movie loop, data have been reported and demon-
strated good consistency and stability within fractions and
throughout the radiotherapy episode.10,11 It was thus likely that
doses received by the heart during treatment would be close to
those predicted from the CT planning study. This work has
enabled quantiﬁcation of that agreement and in 80% of cases,
the differences were no.0.25Gy with none .0.5 Gy. A decrease
in heart dose up to 50% (1.0–2.0 Gy typically) is achieved when
using a breath-hold technique compared with free breathing.9,12
The fraction-to-fraction variations found in this study do not
negate this improvement from the use of breath-holding ra-
diotherapy. In addition, our study showed that good agreement
was observed for both the ABC method and the VBH technique
and was maintained throughout the course of 15 fractions of
treatment. This is reassuring for those already offering breath-
holding treatments to patients and those intending to do so.
Borst et al9 and McIntosh et al12 evaluated metrics such as
maximum dose to the heart and data for the left descending
coronary artery. We selected mean heart dose, as the Darby et al3
Table 1. Predicted and estimated mean heart dose—active breathing control breath-hold
Case
number
CT planning
scan
prediction
15 fractions
(Gy)
Without setup correction Setup correction applied
Predicted
dose 3
fractions
(cGy)
Estimated
dose 3
fractions
from
imaging
data (cGy)
Estimated
dose 15
fractions
from
imaging
data (Gy)
Predicted
dose 3
fractions
(cGy)
Estimated
dose 3
fractions
from
imaging
data (cGy)
Estimated
dose 15
fractions
from
imaging
data (Gy)
1 0.78 15.5 17.8 0.89 15.5 17.9 0.90
2 0.91 18.3 19.0 0.95 18.3 18.9 0.95
3 0.93 18.5 18.2 0.91 18.5 19.4 0.97
4 1.53 30.7 21.9 1.09 30.7 32.8 1.64
5 0.92 18.6 10.3 0.52 18.6 11.2 0.56
6 0.62 12.4 12.3 0.62 12.4 13.2 0.66
7 0.86 17.1 20.9 1.04 17.1 21.8 1.09
8 1.00 20.0 21.2 1.06 20.0 27.7 1.38
9 0.81 16.2 13.8 0.69 16.2 17.8 0.89
10 1.25 25.0 25.2 1.26 25.0 25.3 1.26
11 1.16 23.2 20.0 1.00 23.2 21.5 1.08
12 1.05 21.0 23.3 1.16 21.0 20.7 1.03
13 1.36 27.2 27.6 1.37 27.2 24.2 1.21
14 1.39 27.7 27.0 1.34 27.7 27.7 1.39
15 0.99 19.7 17.5 0.87 19.7 19.1 0.96
16 1.19 23.8 16.5 0.82 23.8 14.8 0.73
17a 0.87
18 0.96 19.2 20.0 1.00 19.2 20.1 1.01
19 0.82 16.5 17.0 0.85 16.5 17.2 0.87
20 1.04 20.9 15.1 0.75 20.9 14.5 0.72
Bold values indicate a change .0.25Gy.
aNot possible to retrieve cone-beam CT images.
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work demonstrated this to be a meaningful metric to enable an
individualized cardiac risk for a female requiring breast radio-
therapy. The quality of the CBCT images meant that whilst it was
possible to contour the heart, outlining small-scale structures such as
the left descending coronary artery was not possible. Hardware
improvements to the CBCT system, which allow gating, will improve
image quality which will assist image registration and outlining. Our
work, and that of Lorenzen et al,15 show that mean heart dose is not
sensitive to large changes in heart volume. If we were to repeat this
study with a gated CBCT, it is unlikely that different results and
conclusions would be obtained even with changed heart outlines.
CONCLUSION
Estimates of the mean heart dose received by patients
undergoing a course of breast cancer radiotherapy varied little
over the treatment duration for two validated, consistent and
stable breath-holding techniques.
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Table 2. Predicted and estimated mean heart dose—voluntary breath-hold
Case
number
CT
planning
scan 15
fractions
(Gy)
Without setup correction Setup correction applied
Predicted
dose 3
fractions
(cGy)
Estimated
dose 3
fractions
from
imaging
data (cGy)
Estimated
dose 15
fractions
from
imaging
data (Gy)
Predicted
dose 3
fractions
(cGy)
Estimated
dose 3
fractions
from
imaging
data (cGy)
Estimated
dose 15
fractions
From
imaging
data (Gy)
1 0.83 16.5 16.5 0.82 16.5 19.8 0.99
2 0.81 16.1 16.7 0.83 16.1 19.3 0.97
3 0.88 17.6 20.3 1.01 17.6 21.6 1.08
4 1.32 26.3 26.1 1.31 26.3 26.6 1.33
5 0.82 16.4 16.9 0.84 16.4 16.8 0.84
6 0.64 12.8 13.4 0.67 12.8 13.6 0.68
7 0.96 19.1 26.1 1.30 19.1 26.0 1.30
8 1.14 22.7 25.0 1.25 22.7 23.6 1.18
9 0.74 14.7 12.6 0.63 14.7 15.3 0.77
10 1.34 26.7 26.1 1.30 26.7 28.2 1.41
11 1.04 20.7 20.5 1.03 20.7 22.5 1.12
12 0.99 19.8 26.9 1.35 19.8 21.5 1.07
13 1.44 28.8 25.9 1.29 28.8 28.2 1.41
14 1.34 26.9 32.0 1.60 26.9 27.2 1.36
15 0.88 17.6 16.6 0.83 17.6 18.1 0.90
16 1.16 23.3 25.3 1.27 23.3 23.2 1.16
17 0.77 15.4 21.0 1.05 15.4 18.9 0.94
18 0.95 18.9 15.9 0.79 18.9 14.4 0.72
19 1.01 20.1 19.0 0.95 20.1 19.8 0.99
20 1.03 20.5 24.0 1.20 20.5 22.0 1.10
Bold values indicate a change .0.25Gy.
Short communication: Mean heart dose variation in breath-holding breast cancer radiotherapy BJR
5 of 6 birpublications.org/bjr Br J Radiol;89:20160536
REFERENCES
1. Darby S, McGale P, Correa C, Taylor C,
Arriagada R, Clarke M, et al; Early Breast
Cancer Trialists’ Collaborative Group. Effect of
radiotherapy after breast- conserving surgery
on 10-year recurrence and 15-year breast
cancer death: meta- analysis of individual
patient data for 10,801 women in 17 rando-
mised trials. Lancet 2011; 378: 1707–16. doi:
http://dx.doi.org/10.1016/S0140-6736(11)
61629-2
2. Clarke M, Collins R, Darby S, Davies C,
Elphinstone P, Evans V, et al; Early Breast
Cancer Trialists’ Collaborative Group.
Effects of radiotherapy and of differences in
the extent of surgery for early breast cancer
on local recurrence and 15-year survival:
an overview of the randomised trials.
Lancet 2005; 366: 2087–106. doi: http://dx.
doi.org/10.1016/S0140-6736(05)67887-7
3. Darby SC, Ewertz M, McGale P, Bennett AM,
Blom-Goldman U, Brønnum D, et al. Risk of
ischemic heart disease in women after
radiotherapy for breast cancer. N Engl J Med
2013; 368: 987–98. doi: http://dx.doi.org/
10.1056/NEJMoa1209825
4. Schubert LK, Gondi V, Sengbusch E,
Westerly DC, Soisson ET, Paliwal BR, et al.
Dosimetric comparision of left-sided whole
breast irradiation with 3DCRT, forward-
planned IMRT, inverse-planned IMRT,
helical tomotherapy and topotherapy.
Radiother Oncol 2011; 100: 241–6.
doi: http://dx.doi.org/10.1016/j.
radonc.2011.01.004
5. Kirby AM, Evans PM, Donovan EM, Conv-
ery HM, Haviland JS, Yarnold JR. Prone
versus supine positioning for whole and
partial breast radiotherapy: a comparison of
non-target tissue dosimetry. Radiother Oncol
2010; 96: 178–84. doi: http://dx.doi.org/
10.1016/j.radonc.2010.05.014
6. Lu HM, Cash E, Chen MH, Chin L, Manning
WJ, Harris J, et al. Reduction of cardiac
volume in left-breast treatment ﬁelds by
respiratory maneuvers: a CTstudy. Int J Radiat
Oncol Biol Phys 2000; 47: 895–904. doi: http://
dx.doi.org/10.1016/S0360-3016(00)00512-5
7. Pedersen AN, Korreman S, Nystro¨m H,
Specht L. Breathing adapted radiotherapy of
breast cancer: reduction of cardiac and
pulmonary doses using voluntary inspiration
breath-hold. Radiother Oncol 2004; 72:
53–60. doi: http://dx.doi.org/10.1016/j.
radonc.2004.03.012
8. Bartlett FR, Colgan RM, Carr K, Donovan
EM, McNair HA, Locke I, et al. The UK
HeartSpare Study: randomised evaluation of
voluntary deep-inspiratory breath-hold in
women undergoing breast radiotherapy.
Radiother Oncol 2013; 108: 242–7. doi:
http://dx.doi.org/10.1016/j.
radonc.2013.04.021
9. Borst GR, Sonke JJ, den Hollander S, Betgen
A, Remeijer P, van Giersbergen A, et al.
Clinical results of image-guided deep in-
spiration breath hold breast irradiation. Int J
Radiat Oncol Biol Phys 2010; 78: 1345–51.
doi: http://dx.doi.org/10.1016/j.
ijrobp.2009.10.006
10. Brouwers PJ, Lustberg T, Borger JH, van
Baardwijk AA, Jager JJ, Murrer LH, et al.
Set-up veriﬁcation and 2-dimensional
electronic portal imaging device dosimetry
during breath hold compared with free
breathing in breast cancer radiation ther-
apy. Pract Radiat Oncol 2015; 5: e135–41.
doi: http://dx.doi.org/10.1016/j.
prro.2014.10.005
11. Colgan R, James M, Bartlett FR, Kirby AM,
Donovan EM. Voluntary breath-holding for
breast cancer radiotherapy is consistent and
stable. Br J Radiol 2015; 88: 20150309. doi:
http://dx.doi.org/10.1259/bjr.20150309
12. McIntosh A, Shoushtair AN, Benedict SH,
Read PW, Wijesooriya K. Quantifying the
reproducibility of heart position during
treatment and corresponding delivered heart
dose in voluntary deep inhalation breath
hold for left breast cancer patients treated
with external beam radiotherapy. Int J Radiat
Oncol Biol Phys 2011; 81: e569–76. doi:
http://dx.doi.org/10.1016/j.
ijrobp.2011.01.044
13. Alderliesten T, Betgen A, Elkhuizen PH, van
Vliet-Vroegindeweij C, Remeijer P. Estima-
tion of heart-position variability in 3D-
surface-image-guided deep-inspiration
breath-hold radiation therapy for left-sided
breast cancer. Radiother Oncol 2013; 109:
442–7. doi: http://dx.doi.org/10.1016/j.
radonc.2013.09.017
14. Donovan EM, Castellano IA, Eagle S, Harris
E. Clinical implementation of kilovoltage
cone beam CT for the veriﬁcation of
sequential and integrated photon boost
treatments for breast cancer patients. Br J
Radiol 2012; 85: E1051–7. doi: http://dx.doi.
org/10.1259/bjr/28845176
15. Lorenzen EL, Taylor CW, Maraldo M,
Neilson MH, Offersen BV, Andersen MR,
et al. Inter-observer variation in delineation
of the heart and left anterior descending
coronary artery in radiotherapy for breast
cancer: a multi-centre study from Denmark
and the UK. Radiother Oncol 2013; 108:
254–8. doi: http://dx.doi.org/10.1016/j.
radonc.2013.06.025
BJR Dunkerley et al
6 of 6 birpublications.org/bjr Br J Radiol;89:20160536
